Search

everythinglearnresearchcommunity

for

Search:↓

Rosacea severely affects the quality of life for many patients in China, especially young adults and those with appearance-related jobs.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

The criteria help doctors diagnose and treat alopecia areata more effectively.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

The patient showed signs of liver disease due to alcohol use but didn't need treatment for Dupuytren’s contracture.

Proper planning for hair transplants is crucial for natural results, with careful patient selection and strategic graft placement being key factors.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Scleroderma patients have lower hair miR-29a levels.

People undergoing chemotherapy need better support and information to cope with hair loss.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Diagnosing PCOS is challenging due to its complex and varied symptoms.

Cultural awareness in healthcare improves patient care and relationships.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

Chemoprevention is rarely used due to concerns about risks, side effects, and lack of clear guidelines.

Most patients stop using topical minoxidil due to side effects.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Neutrophils are key in causing chronic itch in atopic dermatitis, and blocking CXCR3 could reduce this itch.

The conclusion is that the current treatment for hair loss works well for most patients, but better results could be achieved by also focusing on patients' other health issues and habits.

Hair transplants are highly satisfactory for treating female-pattern hair loss.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Contact immunotherapy can improve hair regrowth in alopecia areata patients.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Aesthetic medicine is focusing more on patient needs and using new technologies, but ethical issues and regulation challenges need attention.

Early-onset colorectal cancer requires better physician awareness, risk-based screening, and stigma reduction to improve patient experiences.

Untreated epidermolysis bullosa acquisita can cause total hair and nail loss.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.